Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Introduction Exertional dyspnoea is the primary diagnostic symptom for chronic
cardiopulmonary disease populations. Whilst a number of exercise tests are used, there …

Inhaled bronchodilators (alone or in combination) are the cornerstone of treatment for
symptomatic patients with COPD, either as initial/first-line treatment or for second …

Abstract Tiotropium/olodaterol (Stiolto® Respimat®; Spiolto® Respimat®) is an inhaled fixed-
dose combination of the long-acting muscarinic antagonist tiotropium bromide (hereafter …

The European Respiratory Society journals publish respiratory research and policy
documents of the highest quality, offering a platform for the exchange and promotion of …

Introduction The efficacy of tiotropium/olodaterol compared with tiotropium in patients with
chronic obstructive pulmonary disease (COPD) has been demonstrated in a large clinical …

BACKGROUND: Exercise-induced O2 desaturation contributes to dyspnea and exercise
intolerance in various respiratory diseases. This study assessed whether automated O2 …

Why treatment efficacy on breathlessness in laboratory but n... : Current Opinion in
Supportive and Palliative Care Why treatment efficacy on breathlessness in laboratory but …

Most patients with COPD are recommended to initiate maintenance therapy with a single
long-acting bronchodilator, such as a long-acting muscarinic antagonist or long-acting β2 …

One of the most debilitating symptoms of chronic obstructive pulmonary disease (COPD) is
breathlessness, which leads to avoidance of physical activities in daily living and hastens …